Am. Wagner et al., Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients, DIABET CARE, 22(5), 1999, pp. 812-817
OBJECTIVE - Apolipoprotein(B) (apo(B)] reflects the total mass of atherogen
ic particles (VLDL, IDL, and LDL), and its increase is associated with card
iovascular disease independently of LDL cholesterol (LDLc) levels. Apo(B) d
etermination has been recently standardized, but attention to regional refe
rence limits is advisable. Our aim was to analyze the frequency of dyslipid
emic phenotypes, including those dependent on increased apo(B) in normochol
esterolemic type-2 diabetic patients.
RESEARCH DESIGN AND METHODS - A total of 100 consecutively seen type 2 diab
etic patients (63 men, 37 women; aged 59 +/- 11 years) were included, after
excluding those on lipid-lowering therapy. Apo(B) cutoff(1.1 g/l) was obta
ined from a group of normolipidemic (47 men, 21 women) control subjects, an
d LDLc, triglycerides, and HDL cholesterol (HDLc) cutoff points were those
from the National Cholesterol Education Program guidelines. LDLc levels wer
e obtained by ultracentrifugation if triglyceride levels were >3.45 mmol/l;
otherwise, they were calculated (Friedewald). Apo(B) levels were measured
by immunoturbidimetry.
RESULTS - Normocholesterolemia (LDLc <4.13 mmol/l) appeared in 75 of the 10
0 patients, of whom 55 were normo- and 20 hypertriglyceridemic. Hyperapolip
oprotein(B) [hyperapo(B)] was the most frequent lipid disorder, present in
34 (45%) of the normocholesterolemic patients (22 normo- and 12 hypertrigly
ceridemic). Low HDLc levels were more prevalent (53%) in patients with hype
rapo(B) than in the rest (24%).
CONCLUSIONS - Hyperapo(B) was found in almost half of the normocholesterole
mic type 2 diabetic patients and was frequently associated with low HDLc le
vels and hypertriglyceridemia. Thus, given its independent association with
cardiovascular disease and that it identifies high-risk phenotypes in norm
ocholesterolemic diabetic patients, apo(B) should be used to evaluate the l
ipidic pattern of these patients.